Mithra Pharmaceuticals Pink Sheet Forecast - Naive Prediction
| MITPFDelisted Stock | USD 6.75 0.00 0.00% |
The Naive Prediction forecasted value of Mithra Pharmaceuticals SA on the next trading day is expected to be 6.75 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Mithra Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Mithra Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 23rd of January 2026 the relative strength index (rsi) of Mithra Pharmaceuticals' share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Mithra Pharmaceuticals hype-based prediction, you can estimate the value of Mithra Pharmaceuticals SA from the perspective of Mithra Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Mithra Pharmaceuticals SA on the next trading day is expected to be 6.75 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Mithra Pharmaceuticals after-hype prediction price | USD 6.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mithra |
Mithra Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Mithra price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mithra using various technical indicators. When you analyze Mithra charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Mithra Pharmaceuticals Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of Mithra Pharmaceuticals SA on the next trading day is expected to be 6.75 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict Mithra Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Mithra Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Mithra Pharmaceuticals Pink Sheet Forecast Pattern
| Backtest Mithra Pharmaceuticals | Mithra Pharmaceuticals Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Mithra Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Mithra Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | -9.223372036854776E14 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Mithra Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mithra Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mithra Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Mithra Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mithra Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Mithra Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mithra Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Mithra Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mithra Pharmaceuticals' historical news coverage. Mithra Pharmaceuticals' after-hype downside and upside margins for the prediction period are 6.75 and 6.75, respectively. We have considered Mithra Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mithra Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Mithra Pharmaceuticals is based on 3 months time horizon.
Mithra Pharmaceuticals Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Mithra Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mithra Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mithra Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
6.75 | 6.75 | 0.00 |
|
Mithra Pharmaceuticals Hype Timeline
Mithra Pharmaceuticals is now traded for 6.75. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Mithra is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Mithra Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 6.75. About 32.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.82. Mithra Pharmaceuticals had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be uncertain. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.Mithra Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Mithra Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Mithra Pharmaceuticals' future price movements. Getting to know how Mithra Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mithra Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KARBF | Karo Pharma AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BIESF | Biotest Aktiengesellschaft | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NPRRF | Nipro Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KKPCF | Kaken Pharmaceutical Co | 0.00 | 0 per month | 0.00 | 0.02 | 0.00 | 0.00 | 26.44 | |
| DWRKF | Drgerwerk AG Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CSWYF | China Shineway Pharmaceutical | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TRSSF | Terrascend Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LYPHF | Luye Pharma Group | 0.00 | 0 per month | 0.00 | 0.1 | 0.00 | 0.00 | 49.57 | |
| CCHWF | Columbia Care | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BITGF | Biotage AB | 0.00 | 0 per month | 0.00 | 0.13 | 2.91 | 0.00 | 31.10 |
Mithra Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mithra Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Mithra Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Mithra Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Mithra Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Mithra Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mithra Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Mithra Pharmaceuticals pink sheet market strength indicators, traders can identify Mithra Pharmaceuticals SA entry and exit signals to maximize returns.
Story Coverage note for Mithra Pharmaceuticals
The number of cover stories for Mithra Pharmaceuticals depends on current market conditions and Mithra Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mithra Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mithra Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Mithra Pink Sheet
If you are still planning to invest in Mithra Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mithra Pharmaceuticals' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |